Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,418 public trials 3,293 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Completed

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

NCT00262990

Conditions
Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
Locations
  • Alaska Cancer Research & Education Center Anchorage, Alaska, United States
  • Northern Arizona Hematology & Oncology Associates Flagstaff, Arizona, United States
  • Mayo Center for Women's Health Scottsdale, Arizona, United States
  • Northern Arizona Hematology & Oncology Associates Sedona, Arizona, United States
View all 149 locations
View Trial Details
Completed

Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer

NCT03081494

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Novartis Investigative Site St Leonards, New South Wales, Australia
  • Novartis Investigative Site Murdoch, Western Australia, Australia
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Tel Aviv, Israel
View Trial Details
Completed

Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer

NCT01084330

Conditions
Advanced Gastric Cancer, Digestive System Diseases, Digestive System Neoplasms, +7 more
Locations
  • USC/Kenneth Norris Comprehensive Cancer Center USC/Norris Los Angeles, California, United States
  • University of California at Los Angeles Dept. of UCLA (4) Los Angeles, California, United States
  • Horizon Oncology Center Lafayette, Indiana, United States
  • The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Dept. of SKCC @ JHU Baltimore, Maryland, United States
View all 36 locations
View Trial Details
Completed

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

NCT01155453

Conditions
Advanced and Selected Solid Tumors, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • University of California at Los Angeles Div. of Hematology/Oncology Los Angeles, California, United States
  • University of Texas/MD Anderson Cancer Center Dept of MD Anderson (8) Houston, Texas, United States
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
View Trial Details

Related conditions